HCT Core Topics Connection: Chimeric Antigen Receptor (CAR) T-cell Therapies
-
Register
- Non-member - Free!
- Member - Free!
Already registered?
Log in now.
This module will summarize the mechanism of action and manufacturing process of CAR T-cells, evaluate data supporting the use of the FDA-approved CART T-cell products, and discuss the presentation and management of CAR T-cell toxicities.
Presented by:
Katie S. Gatwood, PharmD, BCOP – Vanderbilt University Medical Center
May T. Aziz, PharmD, BCOP – Virginia Commonwealth University Health System
Key:
Complete
Next
Failed
Available
Locked
Module Recording
Open to view video.
Open to view video.
This module will focus on Chimeric Antigen Receptor (CAR) T-cell Therapies. It is presented by Katie S. Gatwood, PharmD, BCOP and May T. Aziz, PharmD, BCOP.
Module Quiz
10 Questions | 4 attempts | 8/10 points to pass
10 Questions | 4 attempts | 8/10 points to pass
